The literature reports on the subject are inconclusive [19], but our results may provide a rationale for greater emphasis on the diagnosis and treatment of sleep disorders or the use of new drug classes (e.g., ghrelin antagonists/analogs) in the treatment of obesity. Here, GHRL is linked to obesity due to melanocortin 4 receptor deficiency.